Answers are grounded in this paper and cite their sources.
This year sees the first major step towards full disclosure of clinical trial data in Europe. Here we hail the determined campaigners who pushed for this for years and the powerful people who listened
No takes yet. Share an insight, caveat, or question.
Barbara B. Adams (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: